Small Study of GSK Rectal Cancer Drug has Remission in Every Patient – #marketnews

0
361

In a small study of 14 rectal cancer patients, researchers at Memorial Sloan Kettering Cancer Centre (MSKCC) published results where 100% of the 12 patients who completed treatment went into remission.

https://www.washingtontimes.com/news/2022/jun/7/complete-remission-small-cancer-trial-surprises-ex/

This site uses Akismet to reduce spam. Learn how your comment data is processed.